Abstrakt

Evaluation of the pharmacokinetic profile and bioavailability of a new generic formulation of drug y.

Suhayla Beiranvand*

This study aims to assess the pharmacokinetic profile and bioavailability of a new generic formulation of Drug Y. The bioavailability of a drug is a critical factor in determining its efficacy and therapeutic response in patients. In this research, a comparative analysis of the pharmacokinetic parameters between the new generic formulation and the reference product will be conducted. The study will involve a randomized, crossover design with healthy volunteers as participants. Blood samples will be collected at predetermined time intervals, and the concentration-time profiles will be analyzed using non-compartmental analysis. The results will provide valuable insights into the bioequivalence and overall performance of the generic formulation, aiding in its evaluation for regulatory approval and potential clinical use.